We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STUB:NYSEStubHub Holdings, Inc. Analysis

Data as of 2026-09-01 - not real-time

$6.33

Latest Price

9/10Risk

Risk Level: High

Executive Summary

StubHub Holdings, Inc. is priced at $6.33 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 30.9%. Momentum indicators put RSI at 27.6 (oversold) with MACD reading bearish. The recent range runs from support at $6.22 up to resistance at $9.40.
Valuation screens as undervalued: a P/E of 9.5 sits below the sector average of 16.1. Consensus targets land 78.5% above where the shares trade now. Revenue is growing at 33.2% on a -91.3% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 65.7%, a beta of 1.55 and a maximum drawdown of 72.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Upcoming earnings and recent rating move put StubHub Holdings in focus StubHub Holdings STUB has set August 12, 2026,...NEW YORK AP — NEW YORK AP — StubHub Holdings Inc.StubHub Holdings NYSE:STUB reports record Q2 2026 revenue and EBITDA, driven by strong live event demand including the...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 27.6 signals oversold conditions
  • Trading below the 200-day average of 10.01

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 27.6 signals oversold conditions
  • P/E of 9.5 versus sector average of 16.1

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 9.5 versus sector average of 16.1
  • Negative profit margin of -91.3%
  • Analyst targets imply +78.5% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth33.20%
Profit Margin-91.27%
P/E Ratio9.5
ROE-102.95%
ROA-15.03%
Debt/Equity67.20
P/B Ratio1.5
Op. Cash Flow$635.2M
Free Cash Flow$1.1B
Industry P/E16.1

Technical Analysis

TrendBearish
RSI27.6
Support$6.22
Resistance$9.40
MA 20$7.44
MA 50$9.28
MA 200$10.01
MACDBearish
VolumeDecreasing
Fear & Greed Index93.91

Valuation

Fair Value$99.92
Target Price$11.29
Upside/Downside78.52%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.55
Volatility65.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.